Life Sciences

Mercy BioAnalytics, a life sciences company born in Cambridge and now based in Natick, has closed a $41 million Series A financing round.

Employees are on the move at Akoya Biosciences, Milford Regional Medical Center, and MutualOne Bank, with new hires joining operations and promotions happening within organizations.

Holliston biotechnology company Biostage, Inc. has selected Jerry He as its new leader, naming him as CEO and chairman of its board to replace company founder David Green.

The Azzur Group, LLC will break ground on its new Cleanroom on Demand laboratory facility in Devens on April 27.

EyePoint Pharmaceuticals has selected Hopkinton-based Gorman Richardson Lewis Architects to design its 40,000-square-foot facility.

Marlborough firm Akoya Biosciences named Johnny Ek to replace Joe Driscoll as the firm’s CFO, becoming the second new member of the company’s C-suite this year, after Jennifer Kamocsay was picked as general counsel.

The machines in here don’t look like the old science classrooms or even the classrooms we see in movies. Instead, it’s sterile and more like a command center. These machines aren’t for experimentation; they’re to see if your experiment works.

An affiliate of California investment firm, Alexandria Real Estate Equities, Inc., purchased a 35-acre plot of land at 29 Research Drive in Westborough, two months after buying the neighboring former BJ’s Wholesale Club headquarters.

Marlborough-based pharmaceutical company TheracosBio appointed Jeff McGroarty as its first full-time chief financial officer. His appointment comes following regulatory approval of a new diabetes drug, TheracosBio’s first commercial product.

Marlborough medical device company Candela Corp. has received clearance from the U.S. Food & Drug Administration to use the company’s laster system to treat Melasma, a skin condition frequently arising during pregnancy, among other times.